TODD CRAWFORD: Open Payments
NPI 1770563892 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$761 in 36 payments from 14 companies in 2025. Trend: 2023 $373 · 2024 $945 · 2025 $761
Food & beverage: $761
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 8 | $181 |
| AstraZeneca Pharmaceuticals LP | 5 | $92 |
| Novo Nordisk Inc | 3 | $64 |
| BridgeBio Pharma, Inc. | 3 | $61 |
| PFIZER INC. | 2 | $56 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $52 |
| United Therapeutics Corporation | 2 | $51 |
| E.R. Squibb & Sons, L.L.C. | 3 | $48 |
| Alnylam Pharmaceuticals Inc. | 2 | $40 |
| Novartis Pharmaceuticals Corporation | 2 | $33 |
Products named: WINREVAIR, VERQUVO, FARXIGA, Attruby, VYNDAQEL, Kerendia, CAMZYOS, Wegovy.
Industry payments across NC — which companies pay providers there.
